Literature DB >> 18522808

Mice deficient in mitochondrial glycerol-3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid composition.

Tal M Lewin1, Hendrik de Jong, Nicole J M Schwerbrock, Linda E Hammond, Steven M Watkins, Terry P Combs, Rosalind A Coleman.   

Abstract

Glycerol-3-phosphate acyltransferase-1 (GPAT1), which is located on the outer mitochondrial membrane comprises up to 30% of total GPAT activity in the heart. It is one of at least four mammalian GPAT isoforms known to catalyze the initial, committed, and rate-limiting step of glycerolipid synthesis. Because excess triacylglycerol (TAG) accumulates in cardiomyocytes in obesity and type 2 diabetes, we determined whether lack of GPAT1 would alter the synthesis of heart TAG and phospholipids after a 2-week high-sucrose diet or a 3-month high-fat diet. Even in the absence of hypertriglyceridemia, TAG increased 2-fold with both diets in hearts from wildtype mice. In contrast, hearts from Gpat1(-/-) mice contained 20-80% less TAG than the wildtype controls. In addition, hearts from Gpat1(-/-) mice fed the high-sucrose diet incorporate 60% less [(14)C]palmitate into heart TAG as compared to wildtype mice. Because GPAT1 prefers 16:0-CoA to other long-chain acyl-CoA substrates, we determined the fatty acid composition of heart phospholipids. Compared to wildtype littermate controls, hearts from Gpat1(-/-)(-/-) mice contained a lower amount of 16:0 in phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine/phosphatidylinositol and significantly more C20:4n6. Phosphatidylcholine and phosphatidylethanolamine from Gpat1(-/-)(-/-) hearts also contained higher amounts of 18:0 and 18:1. Although at least three other GPAT isoforms are expressed in the heart, our data suggest that GPAT1 contributes significantly to cardiomyocyte TAG synthesis during lipogenic or high-fat diets and influences the incorporation of 20:4n6 into heart phospholipids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18522808      PMCID: PMC3285559          DOI: 10.1016/j.bbalip.2008.05.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  52 in total

1.  Regulation of mitochondrial sn-glycerol-3-phosphate acyltransferase activity: response to feeding status is unique in various rat tissues and is discordant with protein expression.

Authors:  T M Lewin; D A Granger; J H Kim; R A Coleman
Journal:  Arch Biochem Biophys       Date:  2001-12-01       Impact factor: 4.013

Review 2.  Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome.

Authors:  M A Alpert
Journal:  Am J Med Sci       Date:  2001-04       Impact factor: 2.378

3.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.

Authors:  Brian N Finck; John J Lehman; Teresa C Leone; Michael J Welch; Michael J Bennett; Attila Kovacs; Xianlin Han; Richard W Gross; Ray Kozak; Gary D Lopaschuk; Daniel P Kelly
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 4.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

5.  Lipotoxic heart disease in obese rats: implications for human obesity.

Authors:  Y T Zhou; P Grayburn; A Karim; M Shimabukuro; M Higa; D Baetens; L Orci; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

6.  Mitochondrial glycerol phosphate acyltransferase directs the incorporation of exogenous fatty acids into triacylglycerol.

Authors:  R A Igal; S Wang; M Gonzalez-Baró; R A Coleman
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

7.  Molecular defects in sarcolemmal glycerophospholipid subclasses in diabetic cardiomyopathy.

Authors:  A Vecchini; F Del Rosso; L Binaglia; N S Dhalla; V Panagia
Journal:  J Mol Cell Cardiol       Date:  2000-06       Impact factor: 5.000

Review 8.  Lipotoxic diseases of nonadipose tissues in obesity.

Authors:  R H Unger; L Orci
Journal:  Int J Obes Relat Metab Disord       Date:  2000-11

9.  Unique phospholipid metabolism in mouse heart in response to dietary docosahexaenoic or alpha-linolenic acids.

Authors:  S M Watkins; T Y Lin; R M Davis; J R Ching; E J DePeters; G M Halpern; R L Walzem; J B German
Journal:  Lipids       Date:  2001-03       Impact factor: 1.880

10.  A novel mouse model of lipotoxic cardiomyopathy.

Authors:  H C Chiu; A Kovacs; D A Ford; F F Hsu; R Garcia; P Herrero; J E Saffitz; J E Schaffer
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

View more
  22 in total

1.  Pharmacological glycerol-3-phosphate acyltransferase inhibition decreases food intake and adiposity and increases insulin sensitivity in diet-induced obesity.

Authors:  Francis P Kuhajda; Susan Aja; Yajun Tu; Wan Fang Han; Susan M Medghalchi; Rajaa El Meskini; Leslie E Landree; Jonathan M Peterson; Khadija Daniels; Kody Wong; Edward A Wydysh; Craig A Townsend; Gabriele V Ronnett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-13       Impact factor: 3.619

2.  PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.

Authors:  Chin Fung Kelvin Kan; Amar Bahadur Singh; Bin Dong; Vikram Ravindra Shende; Jingwen Liu
Journal:  Biochim Biophys Acta       Date:  2015-01-31

Review 3.  Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling.

Authors:  Rosalind A Coleman; Douglas G Mashek
Journal:  Chem Rev       Date:  2011-06-01       Impact factor: 60.622

Review 4.  MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases.

Authors:  Osama Abo Alrob; Said Khatib; Saleh A Naser
Journal:  J Physiol Biochem       Date:  2016-12-14       Impact factor: 4.158

5.  CHP1 Regulates Compartmentalized Glycerolipid Synthesis by Activating GPAT4.

Authors:  Xiphias Ge Zhu; Shirony Nicholson Puthenveedu; Yihui Shen; Konnor La; Can Ozlu; Tim Wang; Diana Klompstra; Yetis Gultekin; Jingyi Chi; Justine Fidelin; Tao Peng; Henrik Molina; Howard C Hang; Wei Min; Kıvanç Birsoy
Journal:  Mol Cell       Date:  2019-03-04       Impact factor: 17.970

6.  GPAT3 and GPAT4 are regulated by insulin-stimulated phosphorylation and play distinct roles in adipogenesis.

Authors:  Dandan Shan; Jian-liang Li; Leeying Wu; Dongmei Li; Jonathan Hurov; James F Tobin; Ruth E Gimeno; Jingsong Cao
Journal:  J Lipid Res       Date:  2010-02-24       Impact factor: 5.922

7.  Lipid metabolism and toxicity in the heart.

Authors:  Ira J Goldberg; Chad M Trent; P Christian Schulze
Journal:  Cell Metab       Date:  2012-06-06       Impact factor: 27.287

8.  Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation.

Authors:  Angela A Wendel; Daniel E Cooper; Olga R Ilkayeva; Deborah M Muoio; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

9.  Early hepatic insulin resistance in mice: a metabolomics analysis.

Authors:  Lei O Li; Yun-Fu Hu; Lily Wang; Matthew Mitchell; Alvin Berger; Rosalind A Coleman
Journal:  Mol Endocrinol       Date:  2010-02-11

10.  Characterization of a Novel Intestinal Glycerol-3-phosphate Acyltransferase Pathway and Its Role in Lipid Homeostasis.

Authors:  Irani Khatun; Ronald W Clark; Nicholas B Vera; Kou Kou; Derek M Erion; Timothy Coskran; Walter F Bobrowski; Carlin Okerberg; Bryan Goodwin
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.